RaQualia Pharma Balance Sheet

Financials in millions JPY. Fiscal year is January - December.

Millions JPY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	3,240	3,340	3,714	3,675	2,345
Short-Term Investments	3	1	49	250	313
Cash & Short-Term Investments	3,243	3,341	3,763	3,925	2,658
Cash Growth	-2.93%	-11.21%	-4.13%	47.67%	25.79%
Receivables	1,928	689	603	602	1,205
Inventory	159	167	147	8	10
Prepaid Expenses	165	193	188	108	90
Other Current Assets	187	148	255	179	40
Total Current Assets	5,682	4,538	4,956	4,822	4,003
Property, Plant & Equipment	436	529	573	391	299
Long-Term Investments	598	607	1,306	1,020	897
Goodwill	3,700	3,865	-	-	-
Other Intangible Assets	32	37	30	24	33
Long-Term Deferred Tax Assets	64	78	5	-	-
Other Long-Term Assets	2	1	1	-	2
Total Assets	10,514	9,655	6,871	6,257	5,234
Accounts Payable	73	59	54	128	45
Accrued Expenses	58	69	54	60	63
Current Portion of Long-Term Debt	512	512	12	2	-
Current Portion of Leases	78	69	64	42	21
Current Income Taxes Payable	320	221	178	237	230
Other Current Liabilities	234	257	27	24	41
Total Current Liabilities	1,275	1,187	389	493	400
Long-Term Debt	2,138	2,651	39	9	-
Long-Term Leases	171	218	251	167	17
Long-Term Deferred Tax Liabilities	-	-	-	2	16
Other Long-Term Liabilities	35	28	73	89	15
Total Liabilities	3,619	4,084	752	760	448
Common Stock	3,240	2,720	2,667	2,265	2,256
Additional Paid-In Capital	3,430	2,910	2,857	2,455	2,446
Retained Earnings	227	-45	449	773	49
Comprehensive Income & Other	-2	-14	146	4	35
Shareholders' Equity	6,895	5,571	6,119	5,497	4,786
Total Liabilities & Equity	10,514	9,655	6,871	6,257	5,234
Total Debt	2,899	3,450	366	220	38
Net Cash (Debt)	344	-109	3,397	3,705	2,620
Net Cash Growth	-	-	-8.31%	41.41%	26.69%
Net Cash Per Share	14.30	-5.04	157.22	176.57	124.93
Filing Date Shares Outstanding	26.02	21.84	21.62	21.6	20.96
Total Common Shares Outstanding	24.46	21.84	21.62	20.98	20.95
Working Capital	4,407	3,351	4,567	4,329	3,603
Book Value Per Share	281.91	255.10	282.98	262.05	228.43
Tangible Book Value	3,163	1,669	6,089	5,473	4,753
Tangible Book Value Per Share	129.32	76.43	281.60	260.90	226.86

Source: S&P Global Market Intelligence. Standard template. Financial Sources.